High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
about
Combination of bifunctional alkylating agent and arsenic trioxide synergistically suppresses the growth of drug-resistant tumor cellsPhase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor studyPseudoprogression after high-dose busulfan-thiotepa with autologous stem cell transplantation and radiation therapy in children with brain tumors: Impact on survival.Reduced-dose craniospinal radiotherapy followed by tandem high-dose chemotherapy and autologous stem cell transplantation in patients with high-risk medulloblastoma.Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors.Risk-adapted chemotherapy in childhood medulloblastoma.Blood-brain barrier, cytotoxic chemotherapies and glioblastoma.Treatment of recurrent primitive neuroectodermal tumors (PNET) in children and adolescents with high-dose chemotherapy (HDC) and stem cell support: results of the HITREZ 97 multicentre trial.Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.Phase I study of tandem high-dose chemotherapy with autologous peripheral blood stem cell rescue for children with recurrent brain tumors: a Pediatric Blood and MarrowTransplant Consortium study.High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma.Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
P2860
Q28395254-0DCC413A-9038-4C2B-8BDD-8B8319AB74F0Q33409117-3E8E220F-8C26-481F-BCB8-E94CEAB92081Q36344743-A02962AB-F79A-4BBE-8233-326C187C6EBBQ36627160-8BEA2672-984F-47FD-8886-EE91F14FC7E3Q37051060-5BFCBC40-8151-4EC9-A4B8-5AF67120E2D4Q37873471-6BF3E078-7879-44D9-B1FA-F9CF274B8465Q38867048-034AF11A-9420-4525-8717-8B49D40EE833Q41758419-488648A4-1558-47A0-84E3-60761F3DB214Q46512727-BABB4988-6F0F-4E09-8598-AF8C07E303ACQ49065520-41F86AB3-8ADF-4412-B095-8730AD3CC60CQ50728732-C4E715AE-C8C7-41CE-8FB8-3A52DC6167B5Q55463984-1466DB56-DB4D-4392-B1C9-E3CD94BE8543
P2860
High-dose busulfan and thiotepa followed by autologous stem cell transplantation (ASCT) in previously irradiated medulloblastoma patients: high toxicity and lack of efficacy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@ast
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@en
type
label
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@ast
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@en
prefLabel
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@ast
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@en
P2093
P2860
P356
P1476
High-dose busulfan and thiotep ...... toxicity and lack of efficacy.
@en
P2093
Benhamou E
Fillipini B
Habrand JL
Hartmann O
Valteau-Couanet D
P2860
P2888
P304
P356
10.1038/SJ.BMT.1705162
P407
P577
2005-12-01T00:00:00Z
P5875
P6179
1052499533